# A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

> **NCT04070495** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** KW-6356
- **DRUG:** Clarithromycin
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT04070495
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-27
- **Primary completion:** 2019-11-19
- **Final completion:** 2019-11-19
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04070495

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04070495, "A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04070495. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*